Macular Degeneration: Prevention & Management

The macula is a small, sensitive area near the center of your retina responsible for sharp, detailed central vision. It allows you to focus on fine details for activities like recognizing faces, reading, or enjoying hobbies. When the macula is damaged, as in macular degeneration, central vision can become blurry or distorted, but your side vision often remains intact.

Age-related macular degeneration (AMD) comes in two main forms that our ophthalmologists diagnose and treat regularly.

• Dry AMD, the most common type affecting about 85-90% of cases, involves gradual thinning and breakdown of the macula's light-sensitive cells, leading to slow vision loss over time.
• Wet AMD, though less common, progresses more quickly due to the growth of abnormal blood vessels under the retina that leak fluid and cause scarring; it requires prompt intervention to prevent severe damage.

Early dry AMD may cause mild blurring or difficulty adapting to low light, while wet AMD can lead to sudden wavy lines, dark spots, or rapid central vision loss. These changes can make driving, cooking, or recognizing faces harder, but many patients adapt well with our guidance on low-vision aids. At ReFocus Eye Health Danbury, we focus on comprehensive retina services to help you stay independent and active.

AMD develops from a mix of genetic, environmental, and lifestyle factors that harm the macula's cells through oxidative stress, inflammation, and poor blood flow. Aging plays a major role, as natural wear on retinal tissues accumulates over time. While the exact triggers vary, understanding these helps our team at ReFocus Eye Health Danbury tailor prevention strategies for each patient.

AMD mainly impacts adults over 60, with risk rising as you age, though younger people with genetic factors can develop early signs. It is more prevalent in those of Caucasian descent and individuals with a family history. Serving patients throughout the Bridgeport-Stamford-Norwalk metro area, including Danbury, Bethel, Newtown, and Brookfield, our ophthalmologists screen at-risk individuals to catch it early.

AREDS2 supplements, containing vitamins C and E, zinc, copper, lutein, and zeaxanthin, can slow progression in intermediate AMD and now show benefits in late-stage dry AMD by reducing geographic atrophy growth by up to 55%. They are recommended for those at moderate to high risk. Consult our experts to determine if they suit your needs and avoid overuse if risk is low.

For wet AMD, anti-VEGF injections like Eylea or Lucentis target abnormal vessels to stop leakage and preserve vision, often stabilizing or improving sight with regular dosing. Our advanced injection techniques minimize discomfort and are tailored to your response. These therapies have transformed outcomes, with many patients maintaining good vision long-term.

Laser treatments seal leaks in wet AMD, while photodynamic therapy uses a light-sensitive drug to destroy faulty vessels precisely. Though less common now with anti-VEGF advances, they remain options for specific cases. Recovery is swift, and our glaucoma and retina specialists ensure safe application when needed.

Tools like magnifiers, high-contrast screens, and audio devices help adapt to vision changes, promoting independence. We refer to low-vision specialists for training on these aids. Children's vision services extend to all ages, ensuring family-wide support.

Ongoing research includes gene therapies like RGX-314 for wet AMD to produce anti-VEGF naturally, reducing injection frequency, and stem cell approaches for dry AMD to regenerate tissues. Clinical trials for drugs like ABBV-6628 and ASP7317 offer hope. At ReFocus Eye Health Danbury, we keep patients informed about these innovations and trial opportunities.